The cases also serve to illustrate that because of tumor heterogeneity, only certain tumor clones may harbor MET amplification in NSCLC, thereby making their detection challenging in small tumor biopsies [11,31,32]. The gene discussed is MET; the disease is non-small cell lung carcinoma.